AFM notification form MAR 19 - managers transactions
NOTE: As of July 3, 2016, the AFM will only accept digitally completed notification forms!
You can mail the completed notification form to melden@afm.nl
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Dr. Aram Mangasarian |
For natural persons: the first name and the last name(s). | ||
For legal persons: full name including legal form as provided | ||
for in the register where it is incorporated, if applicable. | ||
2. | Reason for the notification | |
a) | Position/ status | Person discharging managerial responsibilities |
For persons discharging managerial responsibilities: the | ||
position occupied within the issuer, emission allowances market | Managing Director / Chief Executive Officer | |
participant/auction platform/auctioneer/auction monitor should | ||
be indicated, e.g. CEO, CFO. | ||
For persons closely associated, | ||
-An indication that the notification concerns a person | ||
closely associated with a person discharging managerial | ||
responsibilities; | ||
- Name and position of the relevant person discharging | ||
managerial responsibilities. | ||
b) | Initial notification/ correction | Initial notification |
Indication that this is an initial notification or a correction to | ||
prior notifications. In case of correction, explain the error that | ||
this notification is correcting. | ||
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) | Name | NOXXON Pharma N.V. |
Full name of the entity | ||
b) | LEI | 724500EPNADXWZ58U595 |
Legal Entity Identifier code in accordance with ISO 17442 LEI | ||
code. |
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of | 1. | Acquisition / Purchase of Shares | |
instrument | |||
2. | |||
Indication as to the nature of the instrument: | |||
- a share, a debt instrument, a derivative or a financial | 3. | ||
instrument linked to a share or a debt instrument; | |||
- an emission allowance, an auction product based on an | 4. | ||
emission allowance or a derivative relating to an emission | |||
allowance. | |||
5. | |||
6. | |||
Instrument identification code (ISIN) | 1. | NL0012044762 | |
2. | |||
3. | |||
4. | |||
5. | |||
6. | |||
b) | Nature of the transaction | 1. | Acquisition / Purchase of Shares |
(i.e. buy, sell, subscription of exchange,…) | |||
2. | |||
Description of the transaction type using, where applicable, the | |||
type of transaction identified in Article 10 of the Commission | 3. | ||
Delegated Regulation (EU) 2016/522(1) adopted under Article | |||
19(14) of Regulation (EU) No 596/2014 or a specific example set | 4. | ||
out in Article 19(7) of Regulation (EU) No 596/2014. | |||
5. | |||
6. | |||
Transaction is linked to the exercise of a share option | 1. | No | ||||||||
programme? Yes/ No | ||||||||||
2. | ||||||||||
3. | ||||||||||
4. | ||||||||||
5. | ||||||||||
6. | ||||||||||
c) | Price(s) and volume(s) | Price (Prices) | Volume(s) | |||||||
1 | 0.0489 | 200,000 | ||||||||
Where more than one transaction of the same nature (i.e. buy, | 0.0496 | 100,000 | ||||||||
sell, subscription of exchange,…) on the same financial | ||||||||||
0.0499 | 14,073 | |||||||||
instrument or emission allowance are executed on the same day | ||||||||||
2 | 0.0509 | 7,900 | ||||||||
and on the same place of transaction, prices and volumes of | ||||||||||
0.0508 | 5,100 | |||||||||
these transactions shall be reported in this field, in a two | ||||||||||
columns form as presented above, inserting as many lines as | ||||||||||
3 | ||||||||||
needed. | ||||||||||
4 | ||||||||||
5 | ||||||||||
6 | ||||||||||
d) | Aggregated information: | Volume | Price | |||||||
- Aggregated volume | (aggregated) | (weigthed average price) | ||||||||
1. | 327,073 | € 0.0492 | ||||||||
- Price | ||||||||||
The volumes of multiple transactions are aggregated when these | 2. | |||||||||
transactions: | ||||||||||
3. | ||||||||||
-relate to the same financial instrument or emission allowance; | ||||||||||
- are of the same nature; | ||||||||||
4. | ||||||||||
-are executed on the same day; and | ||||||||||
-are executed on the same place of transaction. | ||||||||||
5. | ||||||||||
Price information: | ||||||||||
6. | ||||||||||
-In case of a single transaction, the price of the single | ||||||||||
transaction;
-In case the volumes of multiple transactions are aggregated: the weighted average price of the aggregated transactions.
e) | Date of the transaction | 1. | 30-06-2022 |
Date of the particular day of execution of the notified | 2. | ||
transaction. Using the ISO 8601 date format: YYYY-MM-DD | |||
3. | |||
4. | |||
5. | |||
6. | |||
f) | Trading venue/ platform (!)of the transaction | 1. | XPAR (Euronext Growth Paris) |
Name and code to identify the MiFID trading venue, the | 2. | ||
systematic internaliser or the organised trading platform outside | |||
of the Union where the transaction was executed as defined | 3. | ||
under Commission Delegated Regulation supplementing | |||
Regulation (EU) No 600/2014 of the European Parliament and | 4. | ||
of the Council with regard to regulatory technical standards for | |||
5. | |||
the reporting of transactions to competent authorities adopted | |||
under Article 26 of Regulation (EU) No 600/2014, or if the | |||
6. | |||
transaction was not executed on any of the above mentioned | |||
venues, please mention 'outside a trading venue. | |||
Remarks:
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Noxxon Pharma NV published this content on 05 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2022 15:42:09 UTC.